funding header

Archive


Displaying 61 - 80 of 86

 

CSSI Specific Opportunities

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)

RFA-CA-19-027
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)

RFA-CA-19-026
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

RFA-CA-19-025
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional)

RFA-CA-19-024
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional)

RFA-CA-19-023
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

RFA-CA-19-028
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)

RFA-CA-19-022
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

RFA-CA-20-020
Application Receipt Date: February 21, 2020, May 28, 2020, September 29, 2020
Expiration Date: September 30, 2020

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

RFA-CA-20-017
Application Receipt Date: February 21, 2020, May 28, 2020, September 29, 2020
Expiration Date: September 30, 2020

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

RFA-CA-20-018
Application Receipt Date: February 21, 2020, May 28, 2020, September 29, 2020
Expiration Date: September 30, 2020

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

RFA-CA-20-019
Application Receipt Date: February 21, 2020, May 28, 2020, September 29, 2020
Expiration Date: September 30, 2020

Research Answers to NCI’s Provocative Questions (R01 Clinical Trial Optional)

RFA-CA-20-004
Application Receipt Date: June 2, 2020, November 17, 2020
Expiration Date: November 18, 2020

Research Answers to NCI’s Provocative Questions (R21 Clinical Trial Optional)

RFA-CA-20-005
Application Receipt Date: June 2, 2020, November 17, 2020
Expiration Date: November 18, 2020

NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

PAR-20-287
Application Receipt Date: January 4, 2021
Expiration Date: January 5, 2021

NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

PAR-20-288
Application Receipt Date: January 4, 2021
Expiration Date: January 5, 2021

Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)

RFA-CA-20-054
Application Receipt Date: January 15, 2021
Expiration Date: January 16, 2021

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-21-004
Application Receipt Date: February 21, 2021, May 27, 2021, September 29, 2021
Expiration Date: September 29, 2021

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

RFA-CA-21-003
Application Receipt Date: February 22, 2021, May 27, 2021, September 29, 2021
Expiration Date: September 30, 2021

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

RFA-CA-21-005
Application Receipt Date: February 22, 2021, May 27, 2021, September 29, 2021
Expiration Date: September 30, 2021

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-21-006
Application Receipt Date: February 22, 2021, September 27, 2021, September 29, 2021
Expiration Date: September 30, 2021

Pages